On Demand 2016 Skin Diseases Package

Price: $148 members, $220 non-members

You can earn up to 9.5 AMA PRA Category 1 Credit(s)™. 

This package includes sessions from Dermatitis category. 

  • W6 - Office Procedures for Allergic Skin Diseases
  • W14 - Living With An Itch: A Practical Approach to Diagnosis and Treatment
  • W28 - Atopic Dermatitis In-depth
  • W22 - Skin Biopsy of the Allergist: How to Perform and Interpret
  • W26 - Fat Lips and Swollen Throats: What Are the Facts?
  • Modern Therapies for Allergic Skin Diseases

Release Date: 12/01/2016
Expiration Date: 11/30/2019

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 9.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

  • Describe the different tests for physical urticarial and the indications for skin biopsy and interpretation of skin biopsy results
  • Discuss the indications and interpretation of the standard epicutaneous patch testing and the utility of repeat open application testing
  • Demonstrate the application of epicutaneous patch testing
  • Develop strategies for allergist and dermatologist co-management of patients with itch
  • Outline an evidence-based therapeutic ladder for management of itch
  • Outline an evidence-based therapeutic ladder for management of atopic dermatitis
  • Recognize pitfalls in successful management/ reasons for treatment failure
  • Perform a skin biopsy with proper technique and tools
  • Recognize possible complications, adverse effects and limitations of skin biopsy
  • Identify various common interpretations of skin biopsy
  • Discuss the workup and treatment approaches to patients with types 1 and 2 hereditary angioedema (HAE)
  • Discuss the pathophysiology, workup and treatment of histamine-mediated urticaria/angioedema and distinguishing features from type 3 HAE
  • Determine appropriate treatment options and which biologic therapies will benefit patients with atopic dermatitis
  • Discuss the evolving role of the allergist in the diagnosis of contact dermatitis
  • Discuss the approach to patients with pruritus and identify new treatment modalities which will be useful to treat pruritus and other allergic skin diseases
Additional information
Disclosure: 

Michael E. Manning, MD, FACAAI -- Consultant/Advisor: CSL Behring, Dyax, Genentech, Shire

Bruce L. Zuraw, MD, FACAAI -- Consultant/Advisor: Biocryst, Novartis, CSL Behring, Sanofi, Shire, Dyax, Genentech, Alnylan, Arrowhead, Isis

Marc A. Riedl, MD, MS -- Consultant/Advisor: Baxter, Biocryst, CSL Behring, Grifols, Arrowhead, Ionis, Salix, Shire; Speaker: Baxter, CSL Behring, Dyax, Salix, Shire; Supported/ Contracted Research: Amgen, Biocryst, CSL Behring, Dyax, Ionis, Pharming, Shire

Joshua S. Jacobs, MD -- Supported/Contracted Research: AstraZeneca, Biocryst, Circassia, CSL Behring, Dyax, Genentech, Merck, Novartis, Roche, Shire, Teva; Consultant/Advisor: Dyax, Novartis, Roche, Salix, Shire, Teva, Valeant; Speaker: Dyax, Merch, Novartis, Shire, Teva

Luz S. Fonacier, MD, FACAAI -- Consultant/Advisor: Regeneron, Church and Dwight; Speaker: Baxter; Supported/Contracted Research:Baxter, Genentech, Merck

Sharon E. Jacob, MD -- Consultant: Johnson and Johnson, Skintifique; Speaker & Independent Investigator- Smartpractice, USA (makers TRUE Test); Founder-CEO, Dermatitis Academy, free educational online resource

Peter A. Lio, MD -- Consultant/Advisor: Anacor, Galderma, Johnson & Johnson, IntraDerm Pharmaceuticals, Mission, Exeltis, Pierre Fabre, Regeneron, Valeant; Speaker: Anacor, Mission, Pierre Fabre, Regeneron, Valeant

Gil Yosipovitch, MD -- Consultant/Advisor: Anacor, Celgene, Eli Lilly, Johnson & Johnson, Pfizer, Regeneron; Supported/Contracted Research: Allergan, GlaxoSmithKline, Pfizer, Roche

Mark Boguniewicz, MD, FACAAI -- Consultant/Advisor: Regeneron; Supported/ Contracted Research: Anacor, Regeneron

Marcella R. Aquino, MD, FACAAI -- Supported/Contracted Research: Genentech, Merck, Novartis, Roche

William R. Lumry, MD, FACAAI -- Consultant/Advisor: Biocryst, CSL Behring, Dyax, Genentech, Medical Advisory Board–Hereditary Angioedema Association, Roche, Salix, Shire; Speaker: CSL Behring, Dyax, Genentech, Greer, Meda, Medical Advisory Board–Hereditary Angioedema Association, Salix, Shire, Teva; Supported/Contracted Research: ADMA Biologics, Biocryst, CSL Behring, Circassia, Cytos, Dyax, Genentech, Grifols, Kedrion, Mylan, Novartis, Perrigo, Roche, Shire, Teva, Therapure; Board Member for profit organization: Medical Advisory Board–Hereditary Angioedema Association

Richard W. Weber, MD, FACAAI -- Speaker: AstraZeneca, Meda, Merck; Supported/Contracted Research: GlaxoSmithKline, Regeneron

Lawrence F. Eichenfield, MD -- Consultant/Advisor: Anacor, Celgene, Genentech, Otsuka, Regeneron; Supported/Contracted Research: Astellas, Regeneron; Ownership Interest: TopMD

The following have no financial relationship to disclose:

David R. Weldon, MD, FACAAI

This activity is supported by independent educational grants from the following commercial supporters:

AstraZeneca Partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Boston Scientific Supporter of the Virtual Roundtable on Advancing Management of Severe Asthma: A Review of Available Evidence to Guide Current Treatment.

CSL Behring Supporter of the Friday Symposium on Diagnosis and Treatment of Primary Immune Deficiency.

Dormer Laboratories Inc. In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

GlaxoSmithKline Supporter of the Sunday Symposium on What to Do When Asthma Does Not Respond to Step 3 Treatment…and partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Karl Storz Endoscopy-America, Inc. In-kind support consisting of loaned durable equipment for Workshops W12, W15 and W17 – Hands-On Session in Rhinolaryngoscopy.

Meda Pharmaceuticals, Inc. Supporter of the Monday Plenary Session on Asthma in 2016: Advances in Understanding Origin, Presentation and Approaches to Management.

Micro Direct, Inc. In-kind support consisting of loaned durable equipment for Workshops AHP3 and AHP6 Nuts and Bolts of Spirometry Interpretation.

Mylan Specialty L.P. Supporter of the Friday Breakfast Symposium on Leading the Pack: Allergists as Anaphylaxis Experts.

Nestlé Nutrition Institute Supporter of Workshop W11 on Food Allergies: What’s New in Prevention and Treatment.

Regeneron Pharmaceuticals/ Sanofi Genzyme Partial support of the Monday Plenary Session on Modern Therapies for Allergic Skin Diseases.

Salix Pharmaceuticals Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and a video session of the symposium.

Shire Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and the Sunday Symposium on Immunoglobulin Replacement for the Allergist: Update on Guidelines.

SmartPractice In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

Teva Respiratory Supporter of the Friday Symposium on The Use of Biologics in Severe Asthma.

Course summary
Available credit: 
  • 9.50 AMA PRA Category 1 Credit™
  • 9.50 Attendance
  • 1.50 MOC
Course opens: 
12/01/2016
Course expires: 
11/30/2019
Cost:
$220.00
Rating: 
0

Available Credit

  • 9.50 AMA PRA Category 1 Credit™
  • 9.50 Attendance
  • 1.50 MOC

Accreditation Period

Course opens: 
12/01/2016
Course expires: 
11/30/2019

Price

Cost:
$220.00
Please login or create an account to take this course.